"Vacuoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any spaces or cavities within a cell. They may function in digestion, storage, secretion, or excretion.
Descriptor ID |
D014617
|
MeSH Number(s) |
A11.284.430.214.190.875.190.920
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vacuoles".
Below are MeSH descriptors whose meaning is more specific than "Vacuoles".
This graph shows the total number of publications written about "Vacuoles" by people in this website by year, and whether "Vacuoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vacuoles" by people in Profiles.
-
Andersen SE, Bulman LM, Steiert B, Faris R, Weber MM. Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins. Pathog Dis. 2021 02 04; 79(2).
-
Weber MM, Faris R, van Schaik EJ, McLachlan JT, Wright WU, Tellez A, Roman VA, Rowin K, Case ED, Luo ZQ, Samuel JE. The Type IV Secretion System Effector Protein CirA Stimulates the GTPase Activity of RhoA and Is Required for Virulence in a Mouse Model of Coxiella burnetii Infection. Infect Immun. 2016 09; 84(9):2524-33.
-
Weber MM, Bauler LD, Lam J, Hackstadt T. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis. Infect Immun. 2015 Dec; 83(12):4710-8.
-
Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, Schuchter LM, Torigian DA, Panosian JT, Troxel AB, Tan KS, Heitjan DF, DeMichele AM, Vaughn DJ, Redlinger M, Alavi A, Kaiser J, Pontiggia L, Davis LE, O'Dwyer PJ, Amaravadi RK. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy. 2014 Aug; 10(8):1391-402.
-
Delevoye C, Nilges M, Dehoux P, Paumet F, Perrinet S, Dautry-Varsat A, Subtil A. SNARE protein mimicry by an intracellular bacterium. PLoS Pathog. 2008 Mar; 4(3):e1000022.
-
Berger AC, Salazar G, Styers ML, Newell-Litwa KA, Werner E, Maue RA, Corbett AH, Faundez V. The subcellular localization of the Niemann-Pick Type C proteins depends on the adaptor complex AP-3. J Cell Sci. 2007 Oct 15; 120(Pt 20):3640-52.
-
Dalakas MC. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology. 2006 Jan 24; 66(2 Suppl 1):S33-8.
-
Dalakas MC. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol. 2004 Oct; 17(5):561-7.
-
Dalakas MC. The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: a view to the future from the "bench-to-bedside". J Neurol. 2004 Jun; 251(6):651-7.
-
Li M, Dalakas MC. The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis. Neurology. 2000 Apr 25; 54(8):1665-70.